Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin with High-Dose Cytarabine in Refractory/Relapsed AML
NCT00583102Phase 2Terminated
- Sponsor
- University of Iowa
- Start
- Jun 2001
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lovastatin in acute myeloid leukemia (AML), sponsored by University of Iowa. Started Jun 2001; status: terminated.
02
Drugs
lovastatin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00583102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583102.